Literature DB >> 6974725

Asparenomycin A, a new carbapenem antibiotic.

K Tanaka, J Shoji, Y Terui, N Tsuji, E Kondo, M Mayama, Y Kawamura, T Hattori, K Matsumoto, T Yoshida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6974725     DOI： 10.7164/antibiotics.34.909

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  5 in total

1.  Multicenter in vitro evaluation of SM-7338, a new carbapenem.

Authors:  R N Jones; K E Aldridge; S D Allen; A L Barry; P C Fuchs; E H Gerlach; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

Review 2.  In vitro and pharmacokinetic properties of the carbapenems.

Authors:  R Wise
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

3.  Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.

Authors:  F Kobayashi; Y Saino; T Koshi; Y Hattori; M Nakayama; A Iwasaki; T Mori; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

4.  Identification and characterization of the carbapenem MM 4550 and its gene cluster in Streptomyces argenteolus ATCC 11009.

Authors:  Rongfeng Li; Evan P Lloyd; Kristos A Moshos; Craig A Townsend
Journal:  Chembiochem       Date:  2014-01-13       Impact factor: 3.164

5.  The molecular basis for the mode of action of Beta-lactam antibiotics and mechanisms of resistance.

Authors:  B W Bycroft; R E Shute
Journal:  Pharm Res       Date:  1985-01       Impact factor: 4.200
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.